Device type · OYC
Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OYC
Clinical Chemistry
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
9,588
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
- Product code
- OYC
- Device class
- Class III
- Review panel
- Clinical Chemistry
- FDA record
- Classification database entry for OYC
Latest FDA decisions
- t:slim X2 Insulin Pump with Dexcom G5 Mobile CGMPMA supplement
P140015-S020 · Decided Aug 25, 2017 · 177 days after receipt · Panel Track
Device type: Pump, infusion, insulin, to be used with invasive glucose sensor (OYC) · Laboratory Medicine & Pathology
- OneTouch Vibe Plus SystemPMA supplement
P130007-S016 · Decided Dec 16, 2016 · 193 days after receipt · Panel Track
Device type: Pump, infusion, insulin, to be used with invasive glucose sensor (OYC) · Laboratory Medicine & Pathology
P140015 · Decided Sep 8, 2015 · 418 days after receipt
Device type: Pump, infusion, insulin, to be used with invasive glucose sensor (OYC) · Laboratory Medicine & Pathology
Reports received
9,588
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
9,479
99% of reports
Injury reports
108
1.1% of reports
Death reports
1
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1,543 | 22 | 2 | 0 |
| Jan 24 | 2,190 | 23 | 7 | 0 |
| Feb 24 | 1,818 | 7 | 1 | 0 |
| Mar 24 | 1,500 | 24 | 5 | 0 |
| Apr 24 | 1,113 | 9 | 2 | 0 |
| May 24 | 1,656 | 36 | 2 | 0 |
| Jun 24 | 707 | 27 | 1 | 0 |
| Jul 24 | 1,587 | 22 | 4 | 0 |
| Aug 24 | 1,382 | 14 | 3 | 0 |
| Sep 24 | 1,404 | 23 | 2 | 0 |
| Oct 24 | 1,214 | 15 | 0 | 0 |
| Nov 24 | 1,160 | 6 | 0 | 0 |
| Dec 24 | 1,630 | 8 | 0 | 0 |
| Jan 25 | 1,164 | 9 | 0 | 0 |
| Feb 25 | 675 | 3 | 1 | 0 |
| Mar 25 | 1,032 | 2 | 0 | 0 |
| Apr 25 | 1,161 | 7 | 0 | 0 |
| May 25 | 909 | 9 | 0 | 0 |
| Jun 25 | 1,008 | 6 | 2 | 0 |
| Jul 25 | 1,079 | 6 | 1 | 0 |
| Aug 25 | 985 | 7 | 2 | 0 |
| Sep 25 | 1,505 | 4 | 1 | 0 |
| Oct 25 | 1,055 | 3 | 0 | 0 |
| Nov 25 | 658 | 5 | 0 | 0 |
| Dec 25 | 1,061 | 5 | 0 | 0 |
| Jan 26 | 878 | 25 | 0 | 0 |
| Feb 26 | 957 | 11 | 0 | 0 |
| Mar 26 | 842 | 16 | 0 | 0 |
| Apr 26 | 745 | 4 | 1 | 0 |
| May 26 | 621 | 5 | 0 | 0 |
| Jun 26 | 741 | 5 | 0 | 0 |
| Jul 26 | 857 | 2 | 0 | 0 |
| Aug 26 | 629 | 2 | 0 | 0 |
| Sep 26 | 790 | 2 | 0 | 0 |
| Oct 26 | 700 | 26 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Medtronic9,490
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Obstruction of Flow2,193
- Break1,819
- Material Integrity Problem1,319
- Power Problem872
- Key or Button Unresponsive/not Working791
- Mechanical Problem757
- Fracture700
- Battery Problem675
- No Display/Image576
- Display or Visual Feedback Problem316
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions8,874
- Hyperglycemia633
- Hypoglycemia86
- Elevated Ketones/ Diabetic Ketoacidosis50
- Malaise36
- Vomiting26
- Fatigue15
- Headache13
- Discomfort12
- Loss of consciousness8
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1743-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
Z-1745-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
Z-1746-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
- MiniMed 620G Insulin Pump (MMT-1750)Open, Classified
Z-1747-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
- Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722)Open, Classified
Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
- Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)Open, Classified
Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
- Paradigm insulin pump, REF: MMT-754Open, Classified
Z-1257-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
Showing the 8 newest of 34 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.